e-learning
resources
Munich 2006
Sunday 03.09.2006
Screening, diagnosis, staging, prognosis, biological features
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The invasive diagnostics of lung cancer with secondary inflammatory changes
I. M. Kuznetsov, O. B. Ilina, G. S. Zubov, S. A. Shalaev, L. N. Bisenkov (St. Petersburg, Russian Federation)
Source:
Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Session:
Screening, diagnosis, staging, prognosis, biological features
Session type:
E-Posters in free access
Number:
559
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. M. Kuznetsov, O. B. Ilina, G. S. Zubov, S. A. Shalaev, L. N. Bisenkov (St. Petersburg, Russian Federation). The invasive diagnostics of lung cancer with secondary inflammatory changes. Eur Respir J 2006; 28: Suppl. 50, 559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
The clinicofunctional features of patients with lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006
The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006
The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
The primary prevention of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001
Prevalence and characterization of interstitial lung disease in a lung cancer screening program
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
The clinical value of autoflurescence bronchoscopy for precancerous lesions in operable primary lung cancer patients
Source: Annual Congress 2007 - Diagnostic bronchoscopy and transthoracic aspiration
Year: 2007
The relationship between hemoptysis and the features of tumors in primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007
Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept